+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunological studies of group B arthropod-borne virus. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from sub clinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine



Immunological studies of group B arthropod-borne virus. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from sub clinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine



American Journal Trop Medicine Hygiene 15(4): 588-600



The capacity of cross-reacting antibodies to type 1 dengue virus, induced by administration of 17D yellow fever vaccine to human subjects who possessed naturally occurring Japanese encephalitis virus neutralizing antibodies, to protect volunteers against dengue fever upon challenge with unmodified type 1 dengue virus was investigated. These studies, along with the necessary controls, provided the following information: Man appears to be somewhat more susceptible to infection with unmodified type 1 dengue virus than suckling white Swiss mice. Subjects, whose only prior Group B arbovirus experience had been the 17D yellow fever vaccination, did not develop detectable type 1 dengue neutralizing antibodies in response to the YF vaccine and did not display any immunity against type 1 dengue fever. Subjects, whose only previous Group B arbovirus experence had been a subclinical natural infection with Japanese encephalitis virus, did not possess detectable type 1 dengue neutralizing antibodies and did not exhibit immunity against type 1 dengue fever. Subjects with pre-existing Japanese encephalitis virus antibodies developed low levels of type 1 dengue neutralizing antibodies following vaccination with the 17D yellow fever vaccine. Despite this, these subjects developed classical dengue fever when exposed to unmodified type 1 dengue virus. At the onset of symptoms, which was uniformly accompanied by viremia, moderately high levels of neutralizing antibodies had already appeared in the serum.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 024826123

Download citation: RISBibTeXText


Related references

Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 15(4): 588-600, 1966

Immunological studies with group B arthropod-borne viruses, II. Effect of prior infection with Japanese encephalitis virus on the viremia in human subjects following administration of 17D yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 11(4): 562-569, 1962

Immunological studies with group B arthropod-borne viruses. I. Broadened neutralizing antibody spectrum induced by strain 17D yellow fever vaccine in human subjects previously infected with Japanese encephalitis virus. American Journal of Tropical Medicine and Hygiene 11: 550-561, 1962

Immunological studies with group B arthropod-borne viruses. III. Response of human subjects to revaccination with 17D strain yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 11: 570-575, 1962

Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience. American Journal of Tropical Medicine and Hygiene 15(4): 601-610, 1966

Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 12: 230-235, 1963

Immunological studies with Group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 12(2): 230-235, 1962

Immunity in group B arthropod-borne virus diseases; accidental dengue I virus infection in a laboratory worker with antibodies to Japanese encephalitis virus. American Journal of Hygiene 69(1): 60-67, 1959

Epidemics of mosquito borne virus diseases in the pacific area exclusive of dengue and chikungunya viruses with emphasis on the past 5 years human japanese encephalitis murray valley encephalitis venezuelan encephalitis western encephalitis st louis encephalitis ross river virus yellow fever virus. Japanese Journal of Medical Science and Biology 20(SUPP): 7-10, 1967

Infection of graces antheraea eucalypti cells with arboviruses japanese encephalitis virus yellow fever virus st louis encephalitis virus cache valley virus bunyamera virus tahyna virus snowshoe hare virus california group viruses indiana vesicular stomatitis virus. American Journal of Tropical Medicine and Hygiene 17(6): 889-893, 1968

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Human Vaccines 2(2): 60-67, 2006

Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: Biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model. Journal of Virology 77(6): 3655-3668, 2003

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax-Den2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All. Human Vaccines 2(2): 60-67, 2006

Mercapto ethanol sensitive antibody following group b arbovirus infection abstract human yellow fever vaccine west nile virus st louis encephalitis virus. Bacteriological Proceedings 69: 175-176, 1969

Studies of arthropod-borne virus infections in chiroptera. VII. Serologic evidence of natural Japanese B encephalitis virus infection in bats. American Journal of Tropical Medicine and Hygiene 19(1): 88-93, 1970